Q2 Earnings Forecast for CLOV Issued By Leerink Partnrs

Clover Health Investments, Corp. (NASDAQ:CLOV) – Investment analysts at Leerink Partnrs raised their Q2 2026 earnings estimates for Clover Health Investments in a note issued to investors on Wednesday, May 7th. Leerink Partnrs analyst W. Mayo now forecasts that the company will post earnings of $0.06 per share for the quarter, up from their prior forecast of $0.03. The consensus estimate for Clover Health Investments’ current full-year earnings is ($0.12) per share.

Clover Health Investments (NASDAQ:CLOV) last announced its earnings results on Tuesday, May 6th. The company reported $0.05 EPS for the quarter, topping the consensus estimate of ($0.07) by $0.12. The business had revenue of $462.33 million for the quarter, compared to the consensus estimate of $466.93 million. Clover Health Investments had a negative return on equity of 25.46% and a negative net margin of 5.92%.

Separately, Canaccord Genuity Group lifted their price target on Clover Health Investments from $4.20 to $4.50 and gave the company a “buy” rating in a report on Monday, March 3rd.

Clover Health Investments Stock Performance

Shares of CLOV opened at $3.51 on Friday. The stock has a fifty day moving average price of $3.57 and a two-hundred day moving average price of $3.71. The company has a market cap of $1.79 billion, a price-to-earnings ratio of -17.55 and a beta of 1.99. Clover Health Investments has a 52-week low of $0.79 and a 52-week high of $4.87.

Insider Buying and Selling

In other news, General Counsel Karen Soares sold 52,500 shares of the business’s stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $3.80, for a total transaction of $199,500.00. Following the completion of the sale, the general counsel now owns 1,299,663 shares in the company, valued at $4,938,719.40. The trade was a 3.88 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Brady Patrick Priest sold 75,000 shares of the firm’s stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $3.68, for a total value of $276,000.00. Following the completion of the transaction, the chief executive officer now owns 2,418,151 shares in the company, valued at approximately $8,898,795.68. This represents a 3.01 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 327,500 shares of company stock worth $1,197,500 in the last quarter. Insiders own 22.28% of the company’s stock.

Institutional Investors Weigh In On Clover Health Investments

Several institutional investors have recently modified their holdings of the business. Vanguard Group Inc. boosted its stake in Clover Health Investments by 5.1% in the first quarter. Vanguard Group Inc. now owns 20,580,117 shares of the company’s stock valued at $73,883,000 after acquiring an additional 994,904 shares during the last quarter. Geode Capital Management LLC boosted its position in shares of Clover Health Investments by 1.1% in the 4th quarter. Geode Capital Management LLC now owns 4,882,461 shares of the company’s stock worth $15,387,000 after purchasing an additional 53,760 shares during the last quarter. Marshall Wace LLP grew its stake in shares of Clover Health Investments by 167.6% during the fourth quarter. Marshall Wace LLP now owns 3,769,765 shares of the company’s stock worth $11,875,000 after purchasing an additional 2,360,902 shares during the period. Millennium Management LLC increased its holdings in Clover Health Investments by 5,071.2% in the fourth quarter. Millennium Management LLC now owns 1,245,701 shares of the company’s stock valued at $3,924,000 after purchasing an additional 1,221,612 shares during the last quarter. Finally, Northern Trust Corp lifted its stake in Clover Health Investments by 16.0% in the fourth quarter. Northern Trust Corp now owns 1,085,626 shares of the company’s stock valued at $3,420,000 after buying an additional 149,714 shares during the period. Institutional investors and hedge funds own 19.77% of the company’s stock.

About Clover Health Investments

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.